rs9594759 — TNFSF11

Regulatory variant in the RANKL gene affecting bone mineral density and osteoporotic fracture risk

See your personal result for TNFSF11

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

RANKL Regulatory Variant — Guardian of Bone Remodeling Balance

Your TNFSF11 gene encodes RANKL (receptor activator of nuclear factor kappa-B ligand11 receptor activator of nuclear factor kappa-B ligand
a master regulator of bone remodeling), a cytokine that tells your body when to break down old bone through osteoclast activation. Too much RANKL activity tips the balance toward bone loss; too little prevents normal bone turnover. Getting this balance right is essential for maintaining bone strength throughout life, especially as you age.

The Evidence

A validation study in 700 elderly Chinese subjects22 A validation study in 700 elderly Chinese subjects
350 with hip osteoporotic fractures, 350 controls found significant association between TNFSF11 variants including rs9594759 and hip fracture risk (p=0.018). Genome-wide association studies33 Genome-wide association studies
including the landmark 2008 GWAS have consistently identified the TNFSF11 region at chromosome 13q14 as one of the most robust loci associated with bone mineral density variation and osteoporotic fracture risk.

Practical Implications

The good news: bone health is highly modifiable through nutrition and lifestyle. Weight-bearing exercise stimulates bone formation and may help maintain the remodeling balance. Regular bone density screening becomes more important if you have two copies of the T allele, as early detection allows for targeted interventions before fractures occur.

Nutrient Interactions

calcium increased_need
vitamin D increased_need

Genotype Interpretations

What each possible genotype means for this variant.

CC Standard Bone Turnover Normal

Normal RANKL regulation and balanced bone remodeling

You have two copies of the C allele. About 30% of people share this genotype. Your bone remodeling balance should respond typically to dietary calcium, vitamin D, and hormonal signals, without genetic predisposition toward excessive bone resorption.

CT Intermediate Bone Turnover Intermediate

Moderately increased RANKL activity and mildly elevated bone turnover

You have one copy each of the C and T alleles. About 49% of people have this genotype. This genotype represents a modest increase in long-term fracture risk, manageable through proactive bone health strategies.

TT Elevated Bone Turnover High

Increased RANKL activity and elevated bone resorption rate

You have two copies of the T allele. About 21% of people share this genotype. This genetic pattern requires proactive bone health management, particularly during life stages that naturally increase bone loss (menopause, aging, low calcium intake).